KI KIM: Open Payments
NPI 1447683073 · VIENNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 8 payments from 7 companies in 2025. Trend: 2023 $173 · 2024 $291 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $127 |
| Boston Scientific Corporation | 1 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Amgen Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: CARDIOMEMS, WATCHMAN, LEQVIO, REPATHA, VERQUVO, ELIQUIS, FARXIGA.
Industry payments across VA — which companies pay providers there.
